|
Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling Clinical research trials and Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling. Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling clinical trial. Subjects often receive the most expert healthcare possible for their Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling  Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling
Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling
For Condition: Friedreich Ataxia
Status: Completed
Sponsor(s): National Human Genome Research Institute (NHGRI) ,
Synopsis: The purposes of this study are to learn about significant life changes for people with Friedreich's ataxia and about patients' experiences with health care providers. Friedreich's ataxia is a rare genetic disorder in which patients experience progressive muscle weakness and loss of coordination in the arms and legs. They may have other complications, such as vision and hearing impairment, dysarthria, scoliosis, diabetes, and heart disease. The study will explore the impact of this chronic progressive illness on transitional life events, such as career choice and marriage, and the role of family members and health care providers-particularly genetic counselors-in helping patients progress through these events. Patients with Friedreich's ataxia who are 18 years of age or older may be eligible for this study. Those enrolled will participate in a 45- to 60-minute interview by phone or in person, in which they will be asked questions about important changes in their lives and their past experiences with health care providers. The interview will be audiotaped.
Details: Human development across the lifespan is a process of continual change, adaptation and growth. Throughout this process, key transitional events, such as career choice and marriage, mark important points in time when an individual's life course is significantly altered. These transitional events may be instigated by age, historical or idiosyncratic factors. Of particular interest in the present study are patients' perceptions of transitional events brought about or altered by chronic illness and disability. Additionally, factors (i.e. social support, communication, family) that help facilitate progression through these events will be investigated. The actual or potential role of health care providers during transitional events will also be explored with a specific emphasis on genetic counseling. These themes will be examined through the administration of a one-time, semi-structured, in-person or telephone interview of patients with Friedreich's ataxia: a progressive, debilitating, neurodegenerative condition. The interviews will be approximately 45-60 minutes in length and will include open-ended questions to elicit qualitative data. Approximately 40 subjects will be recruited from Friedreich's ataxia support groups, a research organization and a clinical setting. It is anticipated that data elicited from the study will lead to recommendations regarding the process and content of genetic counseling for individuals with Friedreich's ataxia. These considerations, coupled with qualitative data obtained from participants, may also have implications for the evolving role of the genetic counselor. Specifically, consideration of developmental counseling approaches, which emphasize key transitional events, may be particularly useful as genetic counselors become increasingly involved in subspecialties (i.e. cardiology, pediatrics, neurology) that provide continuing follow-up care to patients.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Any individual diagnosed with Friedreich's ataxia, 18 years of age or older, who speaks English and is either in attendance at the NAF conference, or who has access to a telephone. EXCLUSION CRITERIA: Adolescents and children under the age of 18. Children and adolescents will be excluded due to the potiential for increased psychological and/or emotional.
Total Enrollment: 40
Location and Contact Information:
National Human Genome Research Institute (NHGRI)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 030118; 03-HG-0118
Study Start Date: March 4, 2003
Record last reviewed: January 20, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00056186
Other Friedreich Ataxia Studies:
1. Safety Study of Idebenone to Treat Friedreich's Ataxia
2. Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling
Related Studies:
Other Friedreich Ataxia Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Transitional Life Events in Patients with Friedreich's Ataxia: Implications for Genetic Counseling
|
|
|
|
|
|
|
|
